A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
- 15 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (8), 2604-2607
- https://doi.org/10.1182/blood-2006-04-016527
Abstract
The prothrombin 20210A mutation has been associated with an increased risk for venous thromboembolism (VTE) and arterial cardiovascular disease. The risks for asymptomatic carriers of this mutation have thus far been studied only in case-control and retrospective cohort studies. Here we present the results of the first prospective observational study in asymptomatic first-degree family members of patients with either VTE or premature atherosclerosis and the prothrombin 20210A mutation. We included 464 individuals (236 carriers) with a total follow-up duration of 1816 years (943 years for the carriers). The annual incidence of a first VTE was 0.37% (95% CI, 0.08-1.08) for carriers and 0.12% (95% CI, 0.00-0.69) for noncarriers (HR, 3.1; 95% CI, 0.3-29.6). The annual incidence of a first arterial cardiovascular event was 0.56% (95% CI, 0.18-1.31) for carriers and 0.73% (95% CI, 0.27-1.58) for noncarriers (adjusted HR, 0.7; 95% CI, 0.2-2.5). We conclude that the absolute incidence of a first VTE or arterial cardiovascular event is low; therefore, the clinical implications of carriership of the prothrombin 20210A mutation are limited, and routinely testing all first-degree relatives of probands with this mutation does not appear to be justified.This publication has 12 references indexed in Scilit:
- Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)Journal of Thrombosis and Haemostasis, 2005
- Prothrombin 20210A MutationArchives of Internal Medicine, 2004
- The G20210A prothrombin gene mutation: is there room for screening families?Journal of Thrombosis and Haemostasis, 2004
- G20210A Prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjectsHeart, 2004
- Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studiesAmerican Heart Journal, 2003
- Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial InfarctionCirculation, 2001
- A Prospective Study of Asymptomatic Carriers of the Factor V Leiden Mutation To Determine the Incidence of Venous ThromboembolismAnnals of Internal Medicine, 2001
- Low Rate of Venous Thromboembolism in Asymptomatic Relatives of Probands with Factor V Leiden MutationAnnals of Internal Medicine, 1999
- Increased Risk for Venous Thrombosis in Carriers of the Prothrombin G→A^20210 Gene VariantAnnals of Internal Medicine, 1998
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992